PRLD vs UPS · rev $6.5M vs P/E 15, rev $88.66B
Prelude Therapeutics Inc (PRLD) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
PRLD currently screens at market cap $346.5M. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the PRLD and UPS stock pages for the full models.
Not investment advice.